Published in Eur J Endocrinol on April 01, 1999
Suppressive function of androgen receptor in bone resorption. Proc Natl Acad Sci U S A (2003) 1.72
Therapeutic targeting of the prostate cancer microenvironment. Nat Rev Urol (2010) 1.22
Discovery and therapeutic promise of selective androgen receptor modulators. Mol Interv (2005) 0.95
Management of endocrine disease: Secondary osteoporosis: pathophysiology and management. Eur J Endocrinol (2015) 0.83
Osteoporosis in men. J R Soc Med (2001) 0.82
A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res (1998) 4.24
beta-Lactamase proceeds via an acyl-enzyme intermediate. Interaction of the Escherichia coli RTEM enzyme with cefoxitin. Biochemistry (1980) 3.94
Weekend hospitalization and additional risk of death: an analysis of inpatient data. J R Soc Med (2012) 3.77
The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res (2000) 3.38
Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest (2000) 2.94
Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int (2008) 2.74
Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int (2008) 2.72
Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology (1999) 2.69
Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone (1999) 2.69
Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology (1999) 2.65
Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology (1999) 2.27
Idiopathic osteoporosis--is the osteoblast to blame? J Clin Endocrinol Metab (1997) 2.25
Epidemiology of sarcopenia. J Am Geriatr Soc (2000) 1.97
Role of calcium intake in modulating age-related increases in parathyroid function and bone resorption. J Clin Endocrinol Metab (1996) 1.79
Assessing forearm fracture risk in postmenopausal women. Osteoporos Int (2009) 1.71
Genomic imprinting in mammals: an interplay between chromatin and DNA methylation? Trends Genet (1999) 1.67
DNA methylation is linked to deacetylation of histone H3, but not H4, on the imprinted genes Snrpn and U2af1-rs1. Mol Cell Biol (2001) 1.55
Effect of gender on outcomes following renal artery stent placement for renovascular hypertension. Cathet Cardiovasc Diagn (1997) 1.43
The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated. Endocrinology (2000) 1.43
Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology (2001) 1.40
Rotational atherectomy for left anterior descending artery septal perforator stenosis. Catheter Cardiovasc Interv (1999) 1.39
Cross-sectional versus longitudinal evaluation of bone loss in men and women. Osteoporos Int (2000) 1.37
Survival after the diagnosis of hyperparathyroidism: a population-based study. Am J Med (1998) 1.36
The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992. Ann Intern Med (1997) 1.35
Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women. Osteoporos Int (2008) 1.35
Towards a diagnostic and therapeutic consensus in male osteoporosis. Osteoporos Int (2011) 1.33
Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines. Biochem Biophys Res Commun (1998) 1.33
The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group. Osteoporos Int (2014) 1.27
Relationship of bone turnover to bone density and fractures. J Bone Miner Res (1997) 1.26
Clinical performance of parathyroid hormone immunometric assays. Mayo Clin Proc (1992) 1.22
Relationship of intestinal calcium absorption to 1,25-dihydroxyvitamin D [1,25(OH)2D] levels in young versus elderly women: evidence for age-related intestinal resistance to 1,25(OH)2D action. J Clin Endocrinol Metab (2000) 1.22
Bone fragility in men--where are we? Osteoporos Int (2006) 1.19
Beta-lactamase inactivation by mechanism-based reagents. Philos Trans R Soc Lond B Biol Sci (1980) 1.17
Fracture risk among patients with urolithiasis: a population-based cohort study. Kidney Int (1998) 1.17
Epidemiology of sarcopenia. Mayo Clin Proc (2000) 1.17
Relationship of serum leptin levels with body composition and sex steroid and insulin levels in men and women. Metabolism (2000) 1.17
Imprinted expression of neuronatin from modified BAC transgenes reveals regulation by distinct and distant enhancers. Dev Biol (2001) 1.16
The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. Mol Endocrinol (1999) 1.13
Assessment of gene regulation by bone morphogenetic protein 2 in human marrow stromal cells using gene array technology. J Bone Miner Res (2001) 1.09
Effects of raloxifene, a selective estrogen receptor modulator, on bone turnover markers and serum sex steroid and lipid levels in elderly men. J Bone Miner Res (2001) 1.04
Muscle strength in osteoporotic versus normal women. Osteoporos Int (1993) 1.04
Mechanism of renal calcium conservation with estrogen replacement therapy in women in early postmenopause--a clinical research center study. J Clin Endocrinol Metab (1995) 1.02
Phytoestrogen genistein acts as an estrogen agonist on human osteoblastic cells through estrogen receptors alpha and beta. J Cell Biochem (2003) 1.02
The anti-androgen hydroxyflutamide and androgens inhibit interleukin-6 production by an androgen-responsive human osteoblastic cell line. J Bone Miner Res (1999) 1.02
Relative influence of physical activity, muscle mass and strength on bone density. Osteoporos Int (2000) 1.01
Effects of gonadal and adrenal androgens in a novel androgen-responsive human osteoblastic cell line. J Cell Biochem (1998) 0.98
Mutual antagonism of estrogen receptors alpha and beta and their preferred interactions with steroid receptor coactivators in human osteoblastic cell lines. J Endocrinol (2003) 0.97
Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells. Biochem Biophys Res Commun (2001) 0.96
Regulation of osteoclastogenesis and RANK expression by TGF-beta1. J Cell Biochem (2001) 0.96
Effects of the circadian variation in serum cortisol on markers of bone turnover and calcium homeostasis in normal postmenopausal women. J Clin Endocrinol Metab (1998) 0.95
Use of distortion product otoacoustic emissions to assess middle ear transducers in rhesus monkeys. Am J Otol (1995) 0.95
Sclerostin levels during growth in children. Osteoporos Int (2011) 0.93
Relationship of femoral neck areal bone mineral density to volumetric bone mineral density, bone size, and femoral strength in men and women. Osteoporos Int (2011) 0.92
Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption. J Clin Endocrinol Metab (1995) 0.92
Cytokine-specific induction of the TGF-beta inducible early gene (TIEG): regulation by specific members of the TGF-beta family. J Cell Biochem (2000) 0.92
Prospective randomized study of effects of unopposed estrogen replacement therapy on markers of coagulation and inflammation in postmenopausal women. J Clin Endocrinol Metab (2001) 0.91
An ultrastructural study of multifidus muscle in progressive idiopathic scoliosis. Changes resulting from a sarcolemmal defect at the myotendinous junction. J Neurol Sci (1980) 0.91
Idiopathic osteoporosis: a heterogeneous entity. Ann Med Interne (Paris) (1998) 0.91
Non-suppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism. Kidney Int (1996) 0.91
Parathyroid hormone-related protein and hypercalcemia secondary to massive mammary hyperplasia. N Engl J Med (1990) 0.90
The skeletal response to estrogen is impaired in female but not in male steroid receptor coactivator (SRC)-1 knock out mice. Bone (2007) 0.90
Identification of multiple endocrine neoplasia, type 2 gene carriers using linkage analysis and analysis of the RET proto-oncogene. J Clin Endocrinol Metab (1994) 0.89
In vitro and in vivo detection of somatostatin receptors in pheochromocytomas and paragangliomas. J Clin Endocrinol Metab (1992) 0.89
Isolation and characterization of human osteoblasts from needle biopsies without in vitro culture. Osteoporos Int (2013) 0.89
Effects of body size and skeletal site on the estimated prevalence of osteoporosis in women and men. Osteoporos Int (2000) 0.89
Fracture risk after surgery for peptic ulcer disease: a population-based cohort study. Bone (1999) 0.88
Ongoing investigations into an implantable electromagnetic hearing aid for moderate to severe sensorineural hearing loss. Otolaryngol Clin North Am (1995) 0.86
Response of bipotential human marrow stromal cells to insulin-like growth factors: effect on binding protein production, proliferation, and commitment to osteoblasts and adipocytes. Endocrinology (1999) 0.86
Fractures following thyroidectomy in women: a population-based cohort study. Bone (2000) 0.86
Mutations in the RET protooncogene in sporadic pheochromocytomas. J Clin Endocrinol Metab (1995) 0.86
Direct visualization of left ventricular free wall rupture by transesophageal echocardiography in acute myocardial infarction. Am Heart J (1993) 0.86
Estrogen regulation of human osteoblast function is determined by the stage of differentiation and the estrogen receptor isoform. J Cell Biochem (2001) 0.85
Update on primary osteoporosis. Mayo Clin Proc (1997) 0.84
Osteoporosis in men--consensus is premature. Calcif Tissue Int (2004) 0.84
The immunosuppressant rapamycin, alone or with transforming growth factor-beta, enhances osteoclast differentiation of RAW264.7 monocyte-macrophage cells in the presence of RANK-ligand. Calcif Tissue Int (2002) 0.83
Familial medullary thyroid cancer and prominent corneal nerves: clinical and genetic analysis. J Clin Endocrinol Metab (1995) 0.83
Secondary osteoporosis and the risk of distal forearm fractures in men and women. Bone (2002) 0.83
Secondary osteoporosis and the risk of vertebral deformities in women. Bone (1999) 0.83
Genetic testing in medullary thyroid carcinoma syndromes: mutation types and clinical significance. Mayo Clin Proc (1997) 0.83
Estrogen action on bone marrow osteoclast lineage cells of postmenopausal women in vivo. Osteoporos Int (2008) 0.82
Probing chromatin structure with nuclease sensitivity assays. Methods Mol Biol (2001) 0.82
Circulating levels of cytokines that modulate bone resorption: effects of age and menopause in women. J Bone Miner Res (1994) 0.82
Role of estrogen deficiency in pathogenesis of secondary hyperparathyroidism and increased bone resorption in elderly women. Proc Assoc Am Physicians (1997) 0.81
Gorham-Stout disease (phantom bone) of the shoulder girdle. Rheumatology (Oxford) (1999) 0.81
Effects of androgens on the insulin-like growth factor system in an androgen-responsive human osteoblastic cell line. Endocrinology (1999) 0.81
Morphology and distribution of cystic cavities in the normal murine thymus. Cell Tissue Res (1986) 0.81
A defect in renal calcium conservation may contribute to the pathogenesis of postmenopausal osteoporosis. J Clin Endocrinol Metab (1998) 0.81
Genomic imprinting in ruminants: allele-specific gene expression in parthenogenetic sheep. Mamm Genome (1998) 0.80
A fragment of the hypophosphatemic factor, MEPE, requires inducible cyclooxygenase-2 to exert potent anabolic effects on normal human marrow osteoblast precursors. J Cell Biochem (2004) 0.80
Cytokine production in the bone marrow microenvironment: failure to demonstrate estrogen regulation in early postmenopausal women. J Clin Endocrinol Metab (1996) 0.80
Abnormalities of parathyroid hormone secretion in elderly women that are reversible by short term therapy with 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab (1994) 0.80
Novel anthropomorphic hip phantom corrects systemic interscanner differences in proximal femoral vBMD. Phys Med Biol (2014) 0.80
Measurement of gene expression following cryogenic mu-CT scanning of human iliac crest biopsies. J Musculoskelet Neuronal Interact (2003) 0.80
Genetic testing in the diagnosis and management of multiple endocrine neoplasia type II. Ann Intern Med (1995) 0.80
Hepatitis C-associated osteosclerosis: an unusual syndrome of acquired osteosclerosis in adults. Am J Med (1997) 0.80
Immunoradiometric assay for intact human osteocalcin(1-49) without cross-reactivity to breakdown products. Clin Chem (1999) 0.79
Management of postmenopausal osteoporosis for primary care. Menopause (1998) 0.79
The assembly of the adult skeleton during growth and maturation: implications for senile osteoporosis. J Clin Invest (1999) 0.79
Cardiovascular effects of nicotine: relation to deleterious effects of cigarette smoking. Am Heart J (1994) 0.79